Bas van der Baan
2022
In 2022, Bas van der Baan earned a total compensation of $170.4K as Director at LIXTE BIOTECHNOLOGY HOLDINGS.
Compensation breakdown
| Option Awards | $158,525 |
|---|---|
| Other | $11,869 |
| Total | $170,394 |
der Baan received $158.5K in option awards, accounting for 93% of the total pay in 2022.
der Baan also received $11.9K in other compensation.
Rankings
In 2022, Bas van der Baan's compensation ranked 5,447th out of 5,753 executives tracked by ExecPay. In other words, der Baan earned more than 5.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,447 out of 5,753 | 5th |
Division Manufacturing | 2,979 out of 3,133 | 5th |
Major group Chemicals And Allied Products | 1,372 out of 1,419 | 3rd |
Industry group Drugs | 1,280 out of 1,320 | 3rd |
Industry Pharmaceutical Preparations | 933 out of 966 | 3rd |
Source: SEC filing on November 4, 2024.
der Baan's colleagues
We found six more compensation records of executives who worked with Bas van der Baan at LIXTE BIOTECHNOLOGY HOLDINGS in 2022.
2022
René Bernards
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Yun Yen
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Regina Brown
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Stephen Forman
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Philip Palmedo
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Gil Schwartzberg
LIXTE BIOTECHNOLOGY HOLDINGS